A new report published in the Annals of Internal Medicine reveals that it has found no evidence that statins negatively affect the cognitive function in humans.
The US Food and Drug Administration had directed manufacturers to display a warning on statins labels, stating that the drug was linked with confusion and memory loss. The FDA directive came on the back of case reports that linked statins use with a number of side effects.
Statins
Statins are new wonder drugs that are proving to be efficacious, not merely in relieving symptoms but also offering several health benefits.
Advertisement
Researchers led by Dr Karl Richardson and Dr Marisa Schoen reviewed over 25 randomized, controlled trials (RCTs) and cohort, case-control, and cross-sectional studies that studied the effect of statins on patients and found little or no evidence that the drug was linked with adverse cognitive function.
"Low-quality evidence suggested no increased incidence of Alzheimer disease and no difference in cognitive performance in procedural memory, attention, or motor speed. Moderate-quality evidence suggested no increased incidence of dementia or mild cognitive impairment, nor any change in cognitive performance related to global cognitive performance scores, executive function, declarative memory, processing speed, or visuoperception", the researchers wrote in their report.
Source: Medindia
Source: Medindia
Kids With Inherited High Cholesterol may be Helped by Early Statin Therapy
Research says children with inherited high levels of cholesterol who receive cholesterol-lowering statins in their early years have a lower risk.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
